9 completed. 9 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 9 |
| Phase 1 | 3 | Completed 3 |
Follow Albinism: new trials by email Literature Review of Albinism trials Research Report on Albinism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT. ponatinib hydrochloride, laboratory biomarker analysis - Malignant Neoplasm | Phase 2 | Completed | Sameek Roychowdhury | 22 | 2015-02-24 | 2025-03-24 |
| Immune Disorder HSCT Protocol Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan - Immune Deficiency Disorders, Severe Combined Immunodeficiency | Phase 2 | Completed | Washington University School of Medicine | 28 | 2013-04-29 | 2026-10-27 |
| Nitisinone for Type 1B Oculocutaneous Albinism Nitisinone - Albinism, Vision Loss | Phase 1 / Phase 2 | Completed | National Eye Institute (NEI) | 5 | 2013-04-16 | 2019-02-26 |
| Trial of L-DOPA as a Treatment to Improve Vision in Albinism Levodopa, Placebo - Albinism | Phase 2 | Completed | University of Minnesota | 45 | 2010-09-01 | 2018-05-02 |
| Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells Hematopoietic stem cell transplantation - Sickle Cell Disease, Thalassemia | Phase 1 / Phase 2 | Completed | Children's Hospital Los Angeles | 25 | 2008-08-01 | 2016-06-23 |
| Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome Pirfenidone, Placebo - Albinism, Inborn Errors of Metabolism | Phase 2 | Completed | William Gahl, M.D. | 35 | 2005-09-01 | 2017-10-16 |
| A Study of Imatinib With Reinduction Chemotherapy Using Mitoxantrone, Etoposide and Cytarabine in Patients With Relapsed/Refractory C-kit Positive (AML) Acute Myeloid Leukemia Imatinib (Gleevec) - Leukemia | Phase 1 / Phase 2 | Completed | University Health Network, Toronto | 35 | 2004-07-01 | 2015-06-24 |
| Stem Cell Transplant for Immunologic or Histiocytic Disorders Stem Cell Transplant, Fludarabine, Melphalan - Hemophagocytic Lymphohistiocytosis, X-Linked Lymphoproliferative Disorders | Phase 2 | Completed | Masonic Cancer Center, University of Minnesota | 19 | 2002-08-01 | 2017-12-28 |
| A Study of the Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene Imatinib mesylate - Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumor (GIST) | Phase 2 | Completed | Novartis Pharmaceuticals | 148 | 2000-06-01 | 2014-08-19 |
Chediak-Higashi Syndrome (3) · Lymphoproliferative Disorders (3) · Piebaldism (3) · Granulomatous Disease, Chronic (2) · Hyper-IgM Immunodeficiency Syndrome (2) · Immunologic Deficiency Syndromes (2) · Lymphohistiocytosis, Hemophagocytic (2) · Wiskott-Aldrich Syndrome (2) · Albinism, Oculocutaneous (1) · Anemia (1) · Anemia, Dyserythropoietic, Congenital (1) · Anemia, Sickle Cell (1) · Autoimmune Lymphoproliferative Syndrome (1) · Bruton type agammaglobulinemia (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9) · Eye Diseases, Hereditary (9) · Genetic Diseases, Inborn (8) · Metabolic Diseases (8) · Nutritional and Metabolic Diseases (8) · Skin and Connective Tissue Diseases (7) · Amino Acid Metabolism, Inborn Errors (6) · Eye Diseases (6) · Hypopigmentation (6) · Metabolism, Inborn Errors (6) · Pigmentation Disorders (6) · Skin Diseases (6) · Skin Diseases, Genetic (6) · Hematologic Diseases (5)
Imatinib Mesylate (2) · Melphalan (2) · fludarabine (2) · Alemtuzumab (1) · Antilymphocyte Serum (1) · Cyclosporine (1) · Hematopoietic Stem Cell Transplantation (1) · Immunoglobulins, Intravenous (1) · Levodopa (1) · Mycophenolic Acid (1) · Stem Cell Transplantation (1) · Thiotepa (1) · fludarabine phosphate (1) · nitisinone (1) · pirfenidone (1)
Children's Hospital Los Angeles (1) · Masonic Cancer Center, University of Minnesota (1) · National Eye Institute (NEI) (1) · Novartis Pharmaceuticals (1) · Sameek Roychowdhury (1) · University Health Network, Toronto (1) · University of Minnesota (1) · Washington University School of Medicine (1) · William Gahl, M.D. (1)
United States (8) · Australia (1) · Canada (1) · Finland (1)
Angela Smith, MD (1) · Brian P Brooks, M.D. (1) · Gail Summers, M.D. (1) · Hisham Abdel-Azim, MD (1) · Sameek Roychowdhury, MD, PhD (1)